Spots Global Cancer Trial Database for dexrazoxane
Every month we try and update this database with for dexrazoxane cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines | NCT00548704 | Extravasation | Dexrazoxane | 18 Years - | Valerio Therapeutics | |
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | NCT00980460 | PRETEXT I Hepat... PRETEXT II Hepa... PRETEXT III Hep... PRETEXT IV Hepa... | Cisplatin Dexrazoxane Doxorubicin Hyd... Fluorouracil Irinotecan Hydr... Laboratory Biom... Liver Transplan... Temsirolimus Therapeutic Con... Vincristine Sul... | - 21 Years | National Cancer Institute (NCI) | |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | NCT00673179 | Osteosarcoma | Doxorubicin Cisplatin Methotrexate Leucovorin Dexrazoxane Ifosfamide Questionnaire Gemcitabine Sargramostim Surgery Mesna | 5 Years - 40 Years | M.D. Anderson Cancer Center | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients | NCT03698227 | Advanced Soft T... | Olaratumab Dexrazoxane Doxorubicin | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) | NCT00928200 | Relapsed Acute ... Allergy to PEG ... Allergy to Nati... | Erwinase Vincristine Dexamethasone Doxorubicin Cytarabine Methotrexate Triple Intrathe... Dexrazoxane | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT03786783 | Ganglioneurobla... High Risk Neuro... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Dexrazoxane Dinutuximab Doxorubicin Etoposide External Beam R... Isotretinoin Melphalan Sargramostim Thiotepa Topotecan Vincristine | - 30 Years | National Cancer Institute (NCI) | |
| A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines | NCT00548704 | Extravasation | Dexrazoxane | 18 Years - | Valerio Therapeutics | |
| Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane | NCT03930680 | Healthy | Dexrazoxane | 18 Years - 65 Years | University of Arkansas | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines | NCT00548561 | Anthracycline E... | Dexrazoxane | 18 Years - | Valerio Therapeutics | |
| Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL | NCT01523977 | Acute Lymphobla... | Everolimus Prednisone Vincristine PEG-Asparaginas... Doxorubicin Dexrazoxane | 18 Months - 21 Years | Dana-Farber Cancer Institute | |
| A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | NCT01258634 | Osteosarcoma Lung Metastases | Dexrazoxane Doxorubicin Cisplatin G-CSF PEG-filgrastim Etoposide Ifosfamide Mesna Leucovorin | 2 Years - 35 Years | University of Chicago | |
| Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma | NCT02584309 | Sarcoma, Soft T... Soft Tissue Sar... Undifferentiate... Leiomyosarcoma Liposarcoma Synovial Sarcom... Myxofibrosarcom... Angiosarcoma Fibrosarcoma Malignant Perip... Epithelioid Sar... | Dexrazoxane Doxorubicin | 18 Years - | Washington University School of Medicine | |
| Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | NCT01871766 | Rhabdomyosarcom... | Vincristine Dactinomycin Cyclophosphamid... Surgical Resect... Radiation Bevacizumab Sorafenib Myeloid Growth ... Lymph Node Samp... Irinotecan Ifosfamide Etoposide Etoposide Phosp... Doxorubicin Dexrazoxane ^1^1C-methionin... | - 21 Years | St. Jude Children's Research Hospital | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane | NCT03930680 | Healthy | Dexrazoxane | 18 Years - 65 Years | University of Arkansas | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients | NCT03698227 | Advanced Soft T... | Olaratumab Dexrazoxane Doxorubicin | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents | NCT01596088 | Extravasations ... | Dexrazoxane | 20 Years - | Kissei Pharmaceutical Co., Ltd. | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma | NCT01231906 | Localized Extra... Peripheral Prim... Peripheral Prim... | Cyclophosphamid... Dexrazoxane Doxorubicin Hyd... Etoposide Ifosfamide Laboratory Biom... Topotecan Hydro... Vincristine Sul... | - 50 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma | NCT01231906 | Localized Extra... Peripheral Prim... Peripheral Prim... | Cyclophosphamid... Dexrazoxane Doxorubicin Hyd... Etoposide Ifosfamide Laboratory Biom... Topotecan Hydro... Vincristine Sul... | - 50 Years | Children's Oncology Group | |
| Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma | NCT06220032 | DLBCL - Diffuse... | Dexrazoxane Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisolone Lenalidomide Pegfilgrastim | 18 Years - | Stichting Hemato-Oncologie voor Volwassenen Nederland | |
| High-Risk Neuroblastoma Chemotherapy Without G-CSF | NCT02786719 | Neuroblastoma | Topotecan Cyclophosphamid... Cisplatin Etoposide Vincristine Cyclophosphamid... Doxorubicin Sargramostim | 12 Months - 18 Years | Baylor College of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
